Please assess the completion status of the following clinical trial:

Trial Title: Study of Difluprednate in the Treatment of Uveitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of endogenous anterior uveitis in at least 1 eye~Exclusion Criteria:~* Presence of intermediate uveitis, posterior uveitis or panuveitis~* Corneal abrasion~* Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease~* Allergy to similar drugs, such as other corticosteroids

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).